Live
- Youth National Games 2024 kick-start in Delhi; over 5,000 athletes from 15 states vying for top honours
- TN Police warn people against fraudsters using AI-based voice cloning
- L-G office blames Saurabh Bharadwaj for delay in enhancing MCD Commissioner's financial powers
- ICICI Bank posts 17 per cent rise in Q4 net profit at Rs 10,707cr; declares dividend of Rs 10 per share
- 26/11 prosecutor to Mumbai North Central candidate - Ujjwal Nikam all set for 'new innings' with BJP
- CBI traces shop that sold bullets & cartridges seized from Sandeshkhali
- IPL 2024: Rasikh and Mukesh pick three-fers as Delhi Capitals beat Mumbai Indians by 10 runs
- 27 Indian startups secure over $222 million in funding this week
- Final Olympic qualifiers: India's Maheshwari leads the field heading into final day
- Govt allows export of 99,150 tonnes of onion to 6 countries
Cipla gets nod to import Moderna Covid-19 vaccine
Cipla gets nod to import Moderna Covid-19 vaccine
India's drug regulator DCGI has granted permission to Mumbai-based Cipla to import Moderna's COVID-19 vaccine for restricted emergency use in the country, officials said on Tuesday
New Delhi: India's drug regulator DCGI has granted permission to Mumbai-based Cipla to import Moderna's COVID-19 vaccine for restricted emergency use in the country, officials said on Tuesday.
Moderna's vaccine will be the fourth COVID-19 jab to be available in India after Covishield, Covaxin and Sputnik. "An application was received from Moderna through their Indian partner Cipla following which Moderna's COVID-19 vaccine has been granted restricted emergency use authorisation by the drug regulator.
"This new permission for restricted emergency use potentially opens up a clear possibility of this vaccine being imported to India in the near future," NITI Aayog Member (Health) Dr V K Paul said at a press conference.
There are four vaccines with such licensure -- Covishield, Covaxin, Sputnik and Moderna, he said. "Our efforts to invite and to have other internationally developed vaccines specifically Pfizer and J&J also continue. Those processes are on.
We are also looking at increasing the production of availability of vaccines that are being manufactured in our country," Paul added.
In separate communications, Moderna on June 27 informed DCGI that the US government has agreed to donate a certain number of doses of its COVID-19 vaccine through COVAX to India for use here and sought an approval from the Central Drugs Standard Control Organisation (CDSCO).
